Literature DB >> 24271121

Program for evaluating drug dissolution kinetics in preformulation.

M Nicklasson1, A B Magnusson.   

Abstract

The in vitro dissolution kinetics of various drugs were studied at different experimental conditions using both a centrically rotating disc method and a modified excentrically rotating disc method. The combination of these two methods provides a preformulation program that includes many important pharmaceutical and biopharmaceutical parameters related to drug dissolution. The influence of the hydrodynamic conditions on the dissolution rate was demonstrated and the intrinsic dissolution tendency was obtained. Further, the acid dissociation constant, diffusion coefficient and enthalpy of dissolution can be calculated from data obtained from the rotating disc experiments. The relationship between dissolution rate and aqueous solubility of each drug tested is also considered.

Year:  1985        PMID: 24271121     DOI: 10.1023/A:1016333432224

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  14 in total

1.  Convective diffusion model for a transport-controlled dissolution rate process.

Authors:  K G Nelson; A C Shah
Journal:  J Pharm Sci       Date:  1975-04       Impact factor: 3.534

2.  PRECISION APPARATUS FOR DISSOLUTION RATE DETERMINATIONS.

Authors:  G LEVY; W TANSKI
Journal:  J Pharm Sci       Date:  1964-06       Impact factor: 3.534

3.  Analysis of data on the medicament release from ointments.

Authors:  W I HIGUCHI
Journal:  J Pharm Sci       Date:  1962-08       Impact factor: 3.534

4.  Physicochemical properties of amphoteric beta-lactam antibiotics I: Stability, solubility, and dissolution behavior of amino penicillins as a function of pH.

Authors:  A Tsuji; E Nakashima; S Hamano; T Yamana
Journal:  J Pharm Sci       Date:  1978-08       Impact factor: 3.534

5.  Correlation of digoxin-tablet dissolution-rate with biological availability.

Authors:  J Lindenbaum; V P Butler; J E Murphy; R M Cresswell
Journal:  Lancet       Date:  1973-06-02       Impact factor: 79.321

6.  Physiochemical factors influencing the absorption of the anhydrous and trihydrate forms of ampicillin.

Authors:  J W Poole; G Owen; J Silverio; J N Freyhof; S B Rosenman
Journal:  Curr Ther Res Clin Exp       Date:  1968-06

7.  Dissolution rate studies of cholesterol monohydrate in bile acid-lecithin solutions using the rotatingdisk method.

Authors:  S Prakongpan; W I Higuchi; K H Kwan; A M Molokhia
Journal:  J Pharm Sci       Date:  1976-05       Impact factor: 3.534

8.  Dissolution and bioavailability of the anhydrate and trihydrate forms of ampicillin.

Authors:  S A Hill; K H Jones; H Seager; C B Taskis
Journal:  J Pharm Pharmacol       Date:  1975-08       Impact factor: 3.765

9.  Physicochemical properties of amphoteric beta-lactam antibiotics. II: Solubility and dissolution behavior of aminocephalosporins as a function of pH.

Authors:  A Tsuji; E Nakashima; T Yamana
Journal:  J Pharm Sci       Date:  1979-03       Impact factor: 3.534

10.  Improved holder for intrinsic dissolution rate studies.

Authors:  J Wood; J Syarto; H Letterman
Journal:  J Pharm Sci       Date:  1965-07       Impact factor: 3.534

View more
  3 in total

1.  Preformulation study of etoposide: identification of physicochemical characteristics responsible for the low and erratic oral bioavailability of etoposide.

Authors:  J C Shah; J R Chen; D Chow
Journal:  Pharm Res       Date:  1989-05       Impact factor: 4.200

2.  Depth profiling of compression-induced disorders and polymorphic transition on tablet surfaces with grazing incidence X-ray diffraction.

Authors:  Mikko Koivisto; Paula Heinänen; Veli Pekka Tanninen; Vesa-Pekka Lehto
Journal:  Pharm Res       Date:  2006-02-10       Impact factor: 4.200

3.  Freeze Dried Quetiapine-Nicotinamide Binary Solid Dispersions: A New Strategy for Improving Physicochemical Properties and Ex Vivo Diffusion.

Authors:  Ahmed Mahmoud Abdelhaleem Ali; Mayyas Mohammad Ahmad Al-Remawi
Journal:  J Pharm (Cairo)       Date:  2016-11-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.